FOXO1 and type 2 diabetes mellitus: Moreover, studies indicates that as insulin resistance and OS progresses, FoxO1 acts to combat these conditions but over time its protein levels decline causing β-cell dedifferentiation and marking a molecular switch to T2D pathology (165, 166).